336 related articles for article (PubMed ID: 33690870)
1. Clinical Implications of the New WHO Classification 2017 for Pituitary Tumors.
Saeger W; Koch A
Exp Clin Endocrinol Diabetes; 2021 Mar; 129(3):146-156. PubMed ID: 33690870
[TBL] [Abstract][Full Text] [Related]
2. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
3. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
[TBL] [Abstract][Full Text] [Related]
4. Delineating the Spectrum of Pituitary Adenoma Based on the WHO 2017 Classification.
Paramita P; Shilpa R; Nandeesh BN; Yasha TC; Vani S
Neurol India; 2024 Jan; 72(1):96-101. PubMed ID: 38443009
[TBL] [Abstract][Full Text] [Related]
5. Overview of the 2017 WHO Classification of Pituitary Tumors.
Mete O; Lopes MB
Endocr Pathol; 2017 Sep; 28(3):228-243. PubMed ID: 28766057
[TBL] [Abstract][Full Text] [Related]
6. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
[TBL] [Abstract][Full Text] [Related]
7. Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.
Mete O; Gomez-Hernandez K; Kucharczyk W; Ridout R; Zadeh G; Gentili F; Ezzat S; Asa SL
Mod Pathol; 2016 Feb; 29(2):131-42. PubMed ID: 26743473
[TBL] [Abstract][Full Text] [Related]
8. Multihormonal pituitary adenoma concomitant with Pit-1 and Tpit lineage cells causing acromegaly associated with subclinical Cushing's disease: a case report.
Takiguchi T; Koide H; Nagano H; Nakayama A; Fujimoto M; Tamura A; Komai E; Shiga A; Kono T; Higuchi S; Sakuma I; Hashimoto N; Suzuki S; Miyabayashi Y; Ishiwatari N; Horiguchi K; Nakatani Y; Yokote K; Tanaka T
BMC Endocr Disord; 2017 Sep; 17(1):54. PubMed ID: 28865461
[TBL] [Abstract][Full Text] [Related]
9. Steroidogenic Factor 1, Pit-1, and Adrenocorticotropic Hormone: A Rational Starting Place for the Immunohistochemical Characterization of Pituitary Adenoma.
McDonald WC; Banerji N; McDonald KN; Ho B; Macias V; Kajdacsy-Balla A
Arch Pathol Lab Med; 2017 Jan; 141(1):104-112. PubMed ID: 27227698
[TBL] [Abstract][Full Text] [Related]
10. Newer Concepts in the Classification of Pituitary Adenomas.
Sathyakumar R; Chacko G
Neurol India; 2020; 68(Supplement):S7-S12. PubMed ID: 32611886
[TBL] [Abstract][Full Text] [Related]
11. New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors.
Nishioka H; Inoshita N
Brain Tumor Pathol; 2018 Apr; 35(2):57-61. PubMed ID: 29318396
[TBL] [Abstract][Full Text] [Related]
12. Clinical Impact of the Current WHO Classification of Pituitary Adenomas.
Saeger W; Honegger J; Theodoropoulou M; Knappe UJ; Schöfl C; Petersenn S; Buslei R
Endocr Pathol; 2016 Jun; 27(2):104-14. PubMed ID: 26860936
[TBL] [Abstract][Full Text] [Related]
13. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry.
Saeger W; Lüdecke DK; Buchfelder M; Fahlbusch R; Quabbe HJ; Petersenn S
Eur J Endocrinol; 2007 Feb; 156(2):203-16. PubMed ID: 17287410
[TBL] [Abstract][Full Text] [Related]
14. The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas.
Nishioka H; Inoshita N; Mete O; Asa SL; Hayashi K; Takeshita A; Fukuhara N; Yamaguchi-Okada M; Takeuchi Y; Yamada S
Endocr Pathol; 2015 Dec; 26(4):349-55. PubMed ID: 26481628
[TBL] [Abstract][Full Text] [Related]
15. Plurihormonal Pituitary Tumor of Pit-1 and SF-1 Lineages, with Synchronous Collision Corticotroph Tumor: a Possible Stem Cell Phenomenon.
Tordjman KM; Greenman Y; Ram Z; Hershkovitz D; Aizenstein O; Ariel O; Asa SL
Endocr Pathol; 2019 Mar; 30(1):74-80. PubMed ID: 30610567
[TBL] [Abstract][Full Text] [Related]
16. The 2017 WHO classification of pituitary adenoma: overview and comments.
Inoshita N; Nishioka H
Brain Tumor Pathol; 2018 Apr; 35(2):51-56. PubMed ID: 29687298
[TBL] [Abstract][Full Text] [Related]
17. Expression of an orphan nuclear receptor DAX-1 in human pituitary adenomas.
Ikuyama S; Mu YM; Ohe K; Nakagaki H; Fukushima T; Takayanagi R; Nawata H
Clin Endocrinol (Oxf); 1998 May; 48(5):647-54. PubMed ID: 9666878
[TBL] [Abstract][Full Text] [Related]
18. Proposal of a clinically relevant working classification of pituitary neuroendocrine tumors based on pituitary transcription factors.
Silva-Ortega S; García-Martinez A; Niveiro de Jaime M; Torregrosa ME; Abarca J; Monjas I; Picó Alfonso A; Aranda López I
Hum Pathol; 2021 Apr; 110():20-30. PubMed ID: 33321163
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
20. Pit-1 gene expression in human pituitary adenomas.
Pellegrini-Bouiller I; Morange-Ramos I; Barlier A; Gunz G; Enjalbert A; Jaquet P
Horm Res; 1997; 47(4-6):251-8. PubMed ID: 9167960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]